• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® MULTILENGTH URETERAL STENT WITH NICORE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® MULTILENGTH URETERAL STENT WITH NICORE¿ GUIDEWIRE Back to Search Results
Catalog Number 786600
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problems No Patient Involvement (2645); No Information (3190)
Event Date 03/12/2018
Event Type  malfunction  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that there was foreign material (an insect) in the sealing of the stent.
 
Event Description
It was reported that there was foreign material (an insect) in the sealing of the stent.
 
Manufacturer Narrative
The reported issue was confirmed.The device was returned for evaluation.Visual inspection observed a dead insect stuck on the inner wall of the box.Unable to determine how and when the insect was on the inner wall of the box.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use states the following: ¿1) do nor forcibly inserter remove the stent.It may injure patient or/and damage this product.2) avoid improper handling of stent such as bending, kinking, tearing, etc.Misuse could damage the overall integrity of the stent.3) avoid contact with sharp edges as this may cause damage to the stent.If grasping device is used, the stent should be removed from ureter first.Tearing of the stent can be caused by sharp instruments.4) determine the proper stent length for the patient.Selection of too short a stent may result in migration.5) in the event of stent migration, cystoscopy or ureteroscopy should be used to return the stent to the original position or remove from patient body.6) any signs of infection in the location of the stent placement require removal of the stent.After checking the condition of the patient, a new should be placed.7) care should be exercised when removing the stent to eliminate tearing or fragmentation.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® MULTILENGTH URETERAL STENT WITH NICORE¿ GUIDEWIRE
Type of Device
STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key7403375
MDR Text Key105170724
Report Number1018233-2018-01056
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
PMA/PMN Number
K043193
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 04/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Catalogue Number786600
Device Lot NumberMYBXT845
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/30/2018
Initial Date Manufacturer Received 03/15/2018
Initial Date FDA Received04/06/2018
Supplement Dates Manufacturer Received04/20/2018
Supplement Dates FDA Received04/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-